PMID- 28655771 OWN - NLM STAT- MEDLINE DCOM- 20170912 LR - 20210314 IS - 1083-351X (Electronic) IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 292 IP - 34 DP - 2017 Aug 25 TI - p115 RhoGEF activates the Rac1 GTPase signaling cascade in MCP1 chemokine-induced vascular smooth muscle cell migration and proliferation. PG - 14080-14091 LID - S0021-9258(20)34225-3 [pii] LID - 10.1074/jbc.M117.777896 [doi] AB - Although the involvement of Rho proteins in the pathogenesis of vascular diseases is well studied, little is known about the role of their upstream regulators, the Rho guanine nucleotide exchange factors (RhoGEFs). Here, we sought to identify the RhoGEFs involved in monocyte chemotactic protein 1 (MCP1)-induced vascular wall remodeling. We found that, among the RhoGEFs tested, MCP1 induced tyrosine phosphorylation of p115 RhoGEF but not of PDZ RhoGEF or leukemia-associated RhoGEF in human aortic smooth muscle cells (HASMCs). Moreover, p115 RhoGEF inhibition suppressed MCP1-induced HASMC migration and proliferation. Consistent with these observations, balloon injury (BI) induced p115 RhoGEF tyrosine phosphorylation in rat common carotid arteries, and siRNA-mediated down-regulation of its levels substantially attenuated BI-induced smooth muscle cell migration and proliferation, resulting in reduced neointima formation. Furthermore, depletion of p115 RhoGEF levels also abrogated MCP1- or BI-induced Rac1-NFATc1-cyclin D1-CDK6-PKN1-CDK4-PAK1 signaling, which, as we reported previously, is involved in vascular wall remodeling. Our findings also show that protein kinase N1 (PKN1) downstream of Rac1-cyclin D1/CDK6 and upstream of CDK4-PAK1 in the p115 RhoGEF-Rac1-NFATc1-cyclin D1-CDK6-PKN1-CDK4-PAK1 signaling axis is involved in the modulation of vascular wall remodeling. Of note, we also observed that CCR2-G(i/o)-Fyn signaling mediates MCP1-induced p115 RhoGEF and Rac1 GTPase activation. These findings suggest that p115 RhoGEF is critical for MCP1-induced HASMC migration and proliferation in vitro and for injury-induced neointima formation in vivo by modulating Rac1-NFATc1-cyclin D1-CDK6-PKN1-CDK4-PAK1 signaling. CI - (c) 2017 by The American Society for Biochemistry and Molecular Biology, Inc. FAU - Singh, Nikhlesh K AU - Singh NK AD - From the Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163. Electronic address: nsingh2@uthsc.edu. FAU - Janjanam, Jagadeesh AU - Janjanam J AD - From the Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163. FAU - Rao, Gadiparthi N AU - Rao GN AD - From the Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163. Electronic address: rgadipar@uthsc.edu. LA - eng GR - R01 HL064165/HL/NHLBI NIH HHS/United States GR - R01 HL069908/HL/NHLBI NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20170627 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (ARHGEF1 protein, human) RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (RAC1 protein, human) RN - 0 (Rho Guanine Nucleotide Exchange Factors) RN - EC 3.6.5.2 (rac1 GTP-Binding Protein) SB - IM MH - Animals MH - Aorta MH - Carotid Artery Injuries/metabolism/pathology MH - Carotid Artery, Common MH - Cell Movement MH - Cell Proliferation MH - Cells, Cultured MH - Chemokine CCL2/*agonists/metabolism MH - Enzyme Activation MH - Humans MH - *Models, Biological MH - Muscle, Smooth, Vascular/cytology/injuries/*metabolism/pathology MH - Neointima/metabolism/pathology MH - Phosphorylation MH - *Protein Processing, Post-Translational MH - RNA Interference MH - Rats MH - Rho Guanine Nucleotide Exchange Factors/antagonists & inhibitors/genetics/metabolism MH - *Signal Transduction MH - Substrate Specificity MH - Vascular Remodeling MH - rac1 GTP-Binding Protein/*agonists/metabolism PMC - PMC5572933 OTO - NOTNLM OT - NFAT transcription factor OT - cell migration OT - cell proliferation OT - guanine nucleotide exchange factor (GEF) OT - vascular smooth muscle cells COIS- The authors declare that they have no conflicts of interest with the contents of this article EDAT- 2017/06/29 06:00 MHDA- 2017/09/13 06:00 PMCR- 2018/08/25 CRDT- 2017/06/29 06:00 PHST- 2017/01/23 00:00 [received] PHST- 2017/06/20 00:00 [revised] PHST- 2017/06/29 06:00 [pubmed] PHST- 2017/09/13 06:00 [medline] PHST- 2017/06/29 06:00 [entrez] PHST- 2018/08/25 00:00 [pmc-release] AID - S0021-9258(20)34225-3 [pii] AID - M117.777896 [pii] AID - 10.1074/jbc.M117.777896 [doi] PST - ppublish SO - J Biol Chem. 2017 Aug 25;292(34):14080-14091. doi: 10.1074/jbc.M117.777896. Epub 2017 Jun 27.